Follow The Filings

CAH Cardinal Health

Cardinal Health earnings company data as of 10:00 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 2.92 — —
Rev — — —

Insider trades

Open-market buys and sales by CAH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CAH insider trades
  • None no insider bought on the open market
  • $61.6M sold by 8 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Mary C. Scherer Chief Accounting Officer
    Sale
    $546K 2,302 shares at $237.39 45% of stake
    Traded Aug 19 Filed Aug 20
  2. Michelle D. Greene Chief Information Officer
    Sale
    $2.7M 11,650 shares at $235.72 53% of stake
    Traded Aug 18 Filed Aug 20
  3. Deborah Weitzman CEO, PSS Segment
    Sale
    $1.7M 7,354 shares at $235.45 8.6% of stake
    Traded Aug 18 Filed Aug 20
  4. Stephen M Mason CEO, GMPD Segment
    Sale
    $8.3M 35,000 shares at $236.40 66% of stake
    Traded Aug 18 Filed Aug 20
  5. Jessica L Mayer Chief Legal/Compliance Officer
    Sale
    $7M 29,436 shares at $236.19 47% of stake
    Traded Aug 18 Filed Aug 20
  6. Aaron E Alt CFO
    Sale
    $9.9M 42,000 shares at $236.34 67% of stake
    Traded Aug 18 Filed Aug 20
  7. Jason M. Hollar CEO
    Sale
    $29.4M 124,529 shares at $235.89 40% of stake
    Traded Aug 18–19 Filed Aug 20
  8. Michelle D. Greene Chief Information Officer
    Sale
    $627K 2,746 shares at $228.47 18% of stake
    Traded Feb 27 Filed Mar 3
  9. Aaron E Alt CFO
    Sale
    $525K 2,328 shares at $225.50 8.1% of stake
    Traded Feb 18 Filed Feb 18
  10. Patricia Hemingway Hall Director
    Sale
    $919K 4,000 shares at $229.72 12% of stake
    Traded Feb 6 Filed Feb 10

Also filed in the last 12 months, not counted as buying or selling: 29 stock grants and 14 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 7.01,9.01
DEF 14A DEFINITIVE PROXY STATEMENT
DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
SCHEDULE 13G —
8-K 1.01,1.02,2.03,9.01
8-K 2.02,7.01,9.01
10-K
8-K 5.02
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 5.02,7.01,9.01
8-K 5.02

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.